C O M M U N I C A T I O N S
generation, which is consistent with the DLS data; (ii) the burst
release observed for G0 is also consistent with the DLS results;
and (iii) the maximum dye release observed in the case of dendrons
reached a plateau at ∼50%. We attribute this to the possibility that
the rather hydrophobic backbone of our biaryl dendrimers is capable
of solvating a small amount of pyrene. This was supported by the
significant pyrene encapsulation capability of the hydrolyzed G2
carboxylic acid-containing dendron.8
In summary, we have designed dendrimer-based amphiphilic
assemblies that can noncovalently sequester hydrophobic guest
molecules and release these guests in response to an enzymatic
trigger. This was achieved by incorporating enzyme-sensitive
functionalities at the lipophilic face of the dendrons. This feature
causes a change in the HLB when the enzyme is encountered,
effecting disassembly and guest-molecule release. The noncovalent
nature of the binding and release of the guest molecules is likely
to further increase the repertoire of dendrimers in enzyme-
responsive drug delivery systems and biosensors.
Figure 2. Disassembly of dendritic micellar assemblies upon exposure to
PLE: (a) size evolution of the G1 dendritic assembly using DLS; (b) %
release of pyrene using fluorescence studies.
The enzyme-induced disassembly was first investigated using
dynamic light scattering studies. The assembly size in a 25 µM
solution of dendron G1 was ∼100 nm. Upon addition of a 0.1 µM
solution of porcine liver esterase (PLE), we were gratified to find
a systematic decrease with time in the size of the G1 dendron
assembly, which finally reached ∼10 nm after 16 h (Figure 2a).
The final size (10 nm) is identical to the size of the enzyme. This
indicates that the final unaggregated water-soluble dendrons are
not discernible by DLS. To further test whether the disassembly
occurs solely because of the enzymatic hydrolysis of ester func-
tionalities, PLE was added to a solution of the structurally similar
dendron G1-control (Chart 1)7b that lacks ester functionalities. The
lack of disassembly in this case supports the enzyme-specific
disassembly of the G1 micelle-like assembly.8
Acknowledgment. We thank the NIGMS of the National
Institutes of Health and DARPA for support.
Supporting Information Available: Experimental details and NMR,
DLS, and fluorescence data. This material is available free of charge
References
(1) Rijcken, C. J. F.; Soga, O.; Hennink, W. E.; van Nostrum, C. F. J. Controlled
Release 2007, 120, 131–148.
We were also interested in the generation dependence of the
disassembly with respect to the relative kinetics of disassembly.
We conceived that the size of the dendrons would have an effect
on this kinetics. For comparison, we maintained identical concen-
trations of the ester functionalities in all generations. Upon exposure
to PLE, the G2 assembly size was reduced to 10 nm in 24 h, while
G3 took 36 h to reach the same size.8 This generation dependence
of the size evolution is possibly results because the ester function-
alities are less accessible to the enzyme in the tightly packed higher-
generation dendrons. In other words, the higher-generation dendrons
sterically protect the ester functionalities from enzymatic degrada-
tion. The rapid decrease in the size observed for G0 further supports
this hypothesis.8
It is reasonable to expect that the disassembly would effect a
concomitant release of any hydrophobic guest molecule sequestered
within the micellar interior. To test this, PLE was added to the
pyrene-encapsulated dendrons (G0-G3), after which a systematic
decrease in pyrene fluorescence over time was observed (Figure
2b). The temporal evolution of the pyrene fluorescence indicates
that the disassembly was indeed accompanied by release of the
guest. Also, no pyrene release was observed with G1-control, as
expected (Figure 2b).8 Three features are noteworthy: (i) the rate
of guest release systematically decreased with increasing dendron
(2) (a) Almutairi, A.; Guillaudeu, S. J.; Berezin, M. Y.; Achilefu, S.; Fre´chet,
J. M. J. J. Am. Chem. Soc. 2008, 130, 444–445. (b) Bae, Y.; Nishiyama, N.;
Kataoka, K. Bioconjugate Chem. 2007, 18, 1131–1139. (c) Wang, C.; Tam,
K. C.; Jenkins, R. D.; Tan, C. B. J. Phys. Chem. B 2003, 107, 4667–4675.
(d) Lecommandoux, S.; Sandre, O.; Checot, F.; Rodriguez-Hernandez, J.;
Perzynski, R. AdV. Mater. 2005, 17, 712–718. (e) Schmaljohann, D. AdV.
Drug DeliVery ReV. 2006, 58, 1655–1670.
(3) (a) Burke, M. D.; Park, J. O.; Srinivasarao, M.; Khan, S. A. J. Controlled
Release 2005, 104, 141–153. (b) Thornton, P. D.; McConnell, G.; Ulijn,
R. V. Chem. Commun. 2005, 5913–5915.
(4) (a) Grayson, S. M.; Fre´chet, J. M. J. Chem. ReV. 2001, 101, 3819–3867. (b)
Newkome, G. R.; Moorefield, C. N.; Vo¨gtle, F. Dendrimers, 2nd ed.; Wiley-
VCH: Weinheim, Germany, 2001.
(5) (a) Amir, R. J.; Pessah, N.; Shamis, M.; Shabat, D. Angew. Chem., Int. Ed.
2003, 42, 4494–4499. (b) de Groot, F. M. H.; Albrecht, C.; Koekkoek, R.;
Beusker, P. H.; Scheeren, H. W. Angew. Chem., Int. Ed. 2003, 42, 4490–
4494. For a related strategy based on a nonenzymatic trigger, see: (c) Szalai,
M. L.; Kevwitch, R. M.; McGrath, D. V. J. Am. Chem. Soc. 2003, 125,
15688–15689. (d) McGrath, D. V. Mol. Pharm. 2005, 2, 253–263. (e)
Seebach, D.; Herrmann, G. F.; Lengweiler, U. D.; Bachmann, B. M.; Amrein,
W. Angew. Chem., Int. Ed. Engl. 1996, 35, 2795–2797. (f) Schmalenberg,
K. E.; Frauchiger, L.; Nikkhouy-Albers, L.; Uhrich, K. E. Biomacromolecules
2001, 2, 851–855.
(6) (a) Hawker, C. J.; Wooley, K. L.; Fre´chet, J. M. J. J. Chem. Soc., Perkin
Trans. 1 1993, 1287–1297. (b) Newkome, G. R.; Moorefield, C. N.; Baker,
G. R.; Johnson, A. L.; Behera, R. K. Angew. Chem., Int. Ed. Engl. 1991,
30, 1176–1178.
(7) (a) Vutukuri, D. R.; Basu, S.; Thayumanavan, S. J. Am. Chem. Soc. 2004,
126, 15636–15637. (b) Aathimanikandan, S. V.; Savariar, E. N.; Th-
ayumanavan, S. J. Am. Chem. Soc. 2005, 127, 14922–14929.
(8) See the Supporting Information for details.
JA906162U
9
J. AM. CHEM. SOC. VOL. 131, NO. 40, 2009 14185